# A Study of the PK Interaction of CXA-10 With Pravastatin and Vytorin® in Healthy Males

> **NCT02547402** · PHASE1 · COMPLETED · sponsor: **Complexa, Inc.** · enrollment: 10 (actual)

## Conditions studied

- Acute Kidney Injury

## Interventions

- **DRUG:** CXA-10
- **DRUG:** pravastatin
- **DRUG:** Vytorin® (combination of simvastatin and ezetimibe)

## Key facts

- **NCT ID:** NCT02547402
- **Lead sponsor:** Complexa, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-12
- **Primary completion:** 2016-01
- **Final completion:** 2016-02
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2016-05-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02547402

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02547402, "A Study of the PK Interaction of CXA-10 With Pravastatin and Vytorin® in Healthy Males". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02547402. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*